Author

C. Visentin

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Biochemistry· 2 Bioengineering· 1 Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 2 Approach:deep learning· 2 Approach:experimental assay· 2 Organism:human· 2 Organism:mouse· 2 Research Focus:protein folding & dynamics· 2 Research Focus:cell signaling & trafficking· 1 Assay:cryo-EM· 1

Frequent Co-Authors

S. Ricagno· 4 shared A. Bartolome-Nafria· 1 shared A. Brossa· 1 shared A. Chaves-Sanjuan· 1 shared A. Ramon· 1 shared A. Saadeldin· 1 shared A. Salvaggio· 1 shared A. Saturnino· 1 shared

Activity by Year

2022-2023 · peak 3/yr

Co-Author Collaboration Network

10 top collaborators · 17 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

4 shared papersBiochemistry

S. Ricagno

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

AbNatiV: VQ-VAE-based assessment of antibody and nanobody nativeness for hit selection, humanisation, and engineering

A. Ramon, M. Ali, M. Atkinson, A. Saturnino, K. Didi, C. Visentin, S. Ricagno, X. Xu, M. Greenig, P. Sormanni

AbNatiV assesses antibody and nanobody nativeness using a VQ-VAE model, enabling hit selection, humanisation, and engineering with improved performance over conventional methods.

bioRxiv · Apr 28, 2023 · PreprintBioengineering

Cryo-EM Structure of a Mammalian-specific Alternative Amyloid Exon

J. Garcia-Pardo, A. Bartolome-Nafria, A. Chaves-Sanjuan, M. Gil-Garcia, C. Visentin, M. Bolognesi, S. Ricagno, S. Ventura

The paper presents the cryo-EM structure of hnRNPDL-2 amyloid fibrils, showing how alternative splicing controls RNP assembly through an amyloid exon.

bioRxiv · Aug 24, 2022 · PreprintBiochemistry

Goat PRP14 (gPRP14) has xeno-antigenic properties and works as a vaccine in preclinical models of cancer.

S. Minucci, B. Bussolati, P. Massa, A. Brossa, R. Ravasio, M. Saadeldin, G. Degani, E. Papadimitriou, A. Saadeldin, A. Salvaggio, C. Visentin, G. Rizzi, S. Ricagno, L. Popolo, M. A. Vanoni, P. G. Pelicci

This study characterizes gPRP14 as a tumor-specific xeno-antigen that induces anti-tumor immunity in preclinical cancer models.

bioRxiv · Jul 4, 2022 · PreprintCancer Biology

Multi-eGO: an in-silico lens to look into protein aggregation kinetics at atomic resolution

E. Scalone, L. Broggini, C. Visentin, D. Erba, F. Bacic Toplek, K. Peqini, S. Pellegrino, S. Ricagno, C. Paissoni, C. Camilloni

The paper introduces multi-eGO, a computational model that simulates protein aggregation kinetics at atomic resolution, showing agreement with experimental data on Transthyretin peptides.

bioRxiv · Feb 18, 2022Biochemistry